Estrogen Receptor Analyte ControlDR
Estrogen receptor has long been a target for treatment in breast cancer, with the greatest impact occurring with the introduction of Tamoxifen. Tamoxifen is a selective ER modulator (SERM) as it binds to ER causing dimerization yet does not induce the same recruitment of co-activators as the estrogens do. Newer therapies such as the aromatase inhibitors (AI) have demonstrated a greater effectiveness in both the adjuvant and metastatic setting. The ER Dynamic Range Analyte Control contains four cores, offering a full range of expression for ER: Negative, Low, Medium, High
Do you have any questions about this product?
Order your product by email
Productname
Estrogen Receptor Analyte ControlDR
HCL031
By filling out this form, you are placing an order by e-mail. You will receive an order confirmation within one working day. The order cannot be modified after receipt of the order confirmation.
Request a sample
Productname
Estrogen Receptor Analyte ControlDR
HCL031
By filling out this form, you request a sample. You will receive an order confirmation within one working day. The order cannot be modified after receipt of the order confirmation.
Are you looking for specific products, alternatives or documentation?
